Another study in which a bacterial toxin (cytolethal distending toxin) was conjugated to an anti-human CD133 monoclonal antibody demonstrated inhibition of CD133+-induced cell proliferation in cultures of established HNSCC cell lines [186]. This evidence concerns the gene PROM1 and head and neck squamous cell carcinoma.